Malaria biology and disease pathogenesis: insights for new treatments.
Reads0
Chats0
TLDR
The current understanding of the biology of asexual blood-stage parasites and gametocytes and the ability to culture them in vitro lends optimism that high-throughput screenings of large chemical libraries will produce a new generation of antimalarial drugs.Abstract:
Plasmodium falciparum malaria, an infectious disease caused by a parasitic protozoan, claims the lives of nearly a million children each year in Africa alone and is a top public health concern. Evidence is accumulating that resistance to artemisinin derivatives, the frontline therapy for the asexual blood stage of the infection, is developing in southeast Asia. Renewed initiatives to eliminate malaria will benefit from an expanded repertoire of antimalarials, including new drugs that kill circulating P. falciparum gametocytes, thereby preventing transmission. Our current understanding of the biology of asexual blood-stage parasites and gametocytes and the ability to culture them in vitro lends optimism that high-throughput screenings of large chemical libraries will produce a new generation of antimalarial drugs. There is also a need for new therapies to reduce the high mortality of severe malaria. An understanding of the pathophysiology of severe disease may identify rational targets for drugs that improve survival.read more
Citations
More filters
Journal ArticleDOI
Structure and function of the immune system in the spleen
TL;DR: This review will focus on cell types, cell organization, and immunologic functions specific to the spleen and how these affect initiation of adaptive immunity to systemic blood-borne antigens.
Journal ArticleDOI
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips,Julie Lotharius,Kennan C. Marsh,John H. White,Anthony Dayan,Karen L. White,Jacqueline W. Njoroge,Farah El Mazouni,Yanbin Lao,Sreekanth Kokkonda,Diana R. Tomchick,Xiaoyi Deng,Trevor Laird,Sangeeta N. Bhatia,Sandra March,Caroline L. Ng,David A. Fidock,Sergio Wittlin,Sergio Wittlin,Maria J. Lafuente-Monasterio,Francisco Javier Gamo Benito,Laura Maria Sanz Alonso,María Santos Martínez,María Belén Jiménez-Díaz,Santiago Ferrer Bazaga,Iñigo Angulo-Barturen,John N. Haselden,James B. Louttit,Yi Cui,Arun Sridhar,Anna Marie Zeeman,Clemens H. M. Kocken,Robert W. Sauerwein,Koen J. Dechering,Vicky M. Avery,Sandra Duffy,Michael J. Delves,Robert E. Sinden,Andrea Ruecker,Kristina S. Wickham,Rosemary Rochford,Janet Gahagen,Lalitha V. Iyer,Ed Riccio,Jon C. Mirsalis,Ian Bathhurst,Thomas Rueckle,Xavier C. Ding,Brice Campo,Didier Leroy,M. John Rogers,Pradipsinh K. Rathod,Jeremy N. Burrows,Susan A. Charman +53 more
TL;DR: DSM265, a triazolopyrimidine-based inhibitor of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH), is the first DHODH inhibitor to reach clinical development for treatment of malaria as discussed by the authors.
Journal ArticleDOI
Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.
Peter D. Crompton,Jacqueline Moebius,Silvia Portugal,Michael Waisberg,Geoffrey T. Hart,Lindsey S. Garver,Louis H. Miller,Carolina Barillas-Mury,Susan K. Pierce +8 more
TL;DR: What is known about the mechanisms at play in immune resistance to malaria in both the human and mosquito hosts at each step in the parasite's complex life cycle is reviewed with a view toward developing the tools that will contribute to the prevention of disease and death and, ultimately, to the goal of malaria eradication.
Journal ArticleDOI
Innate sensing of malaria parasites
TL;DR: The cellular and molecular mechanisms by which Plasmodium infection is sensed by different families of innate immune receptors are highlighted and how these events mediate both host resistance to infection and the pathogenesis of malaria is discussed.
Journal ArticleDOI
Toxoplasma Effectors Targeting Host Signaling and Transcription
TL;DR: These effectors highlight novel mechanisms by which T. gondii has learned to harness host signaling to favor intracellular survival and will guide future studies designed to uncover the additional complexity of this intricate host-pathogen interaction.
References
More filters
Journal ArticleDOI
Artemisinin Resistance in Plasmodium falciparum Malaria
Arjen M. Dondorp,François Nosten,Poravuth Yi,Debashish Das,Aung Phae Phyo,Joel Tarning,Khin Maung Lwin,Frédéric Ariey,Warunee Hanpithakpong,Sue J. Lee,Pascal Ringwald,Kamolrat Silamut,Mallika Imwong,Kesinee Chotivanich,Pharath Lim,Trent Herdman,Sen Sam An,Shunmay Yeung,Pratap Singhasivanon,Nicholas P. J. Day,Niklas Lindegardh,Duong Socheat,Nicholas J. White +22 more
TL;DR: The overall median clearance times were 84 hours (interquartile range, 60 to 96) in Pailin and 48 hours in Wang Pha (P<0.001) in each of the two locations as discussed by the authors.
Journal ArticleDOI
The reaction of no with superoxide
Robert E. Huie,S. Padmaja +1 more
TL;DR: The rate constant for the reaction of NO with .O2- was determined to be (6.7 +/- 0.9) x 10(9) l mol-1 s-1, considerably higher than previously reported.
Journal ArticleDOI
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
R. De Caterina,Peter Libby,Hai-Bing Peng,Victor J. Thannickal,Tripathi B. Rajavashisth,Michael A. Gimbrone,Wee Soo Shin,James K. Liao +7 more
TL;DR: It is proposed that nitric oxide's ability to limit endothelial activation and inhibit monocyte adhesion may contribute to some of its antiatherogenic and antiinflammatory properties within the vessel wall.
Journal ArticleDOI
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.
Kenyatta Cosby,Kristine S. Partovi,Jack H. Crawford,Rakesh P. Patel,Christopher D. Reiter,Sabrina Martyr,Benjamin K. Yang,Myron A. Waclawiw,Gloria Zalos,Xiuli Xu,Kris T. Huang,Howard Shields,Daniel B. Kim-Shapiro,Alan N. Schechter,Richard O. Cannon,Mark T. Gladwin +15 more
TL;DR: It is suggested that nitrite represents a major bioavailable pool of NO, and a new physiological function for hemoglobin as a nitrite reductase is described, potentially contributing to hypoxic vasodilation.
Journal ArticleDOI
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
TL;DR: Artemisinins are potent and rapidly acting antimalarial drugs, and their widespread use for treating patients with Plasmodium falciparum malaria raises the question of emerging drug resistance.
Related Papers (5)
Genome sequence of the human malaria parasite Plasmodium falciparum
Malcolm J. Gardner,Neil Hall,Eula Fung,Owen White,Matthew Berriman,Richard W. Hyman,Jane M. Carlton,Arnab Pain,Karen E. Nelson,Sharen Bowman,Ian T. Paulsen,Keith D. James,Jonathan A. Eisen,Kim Rutherford,Steven L. Salzberg,Alister Craig,Sue Kyes,Man Suen Chan,Vishvanath Nene,Shamira J. Shallom,Bernard B. Suh,Jeremy Peterson,Samuel V. Angiuoli,Mihaela Pertea,Jonathan E. Allen,Jeremy D. Selengut,Daniel H. Haft,Michael W. Mather,Akhil B. Vaidya,David M. A. Martin,Alan H. Fairlamb,Martin Fraunholz,David S. Roos,Stuart A. Ralph,Geoffrey I. McFadden,Leda M. Cummings,G. Mani Subramanian,Christopher J. Mungall,J. Craig Venter,Daniel J. Carucci,Stephen L. Hoffman,Chris I. Newbold,Ronald W. Davis,Claire M. Fraser,Bart Barrell +44 more
Artemisinin Resistance in Plasmodium falciparum Malaria
Arjen M. Dondorp,François Nosten,Poravuth Yi,Debashish Das,Aung Phae Phyo,Joel Tarning,Khin Maung Lwin,Frédéric Ariey,Warunee Hanpithakpong,Sue J. Lee,Pascal Ringwald,Kamolrat Silamut,Mallika Imwong,Kesinee Chotivanich,Pharath Lim,Trent Herdman,Sen Sam An,Shunmay Yeung,Pratap Singhasivanon,Nicholas P. J. Day,Niklas Lindegardh,Duong Socheat,Nicholas J. White +22 more